Erik Corcoran

Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer

Yan Wu, Zhaojing Zhong, James Huber et al. · Clinical Cancer Research · 2006 · 151 citations

Medicine, Cancer Biology, Oncology +17

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Jaya Julie Joshi, Heather Coffey, Erik Corcoran et al. · Cancer Research · 2017 · 151 citations

Medicine, Oncology, Pharmacology +15

Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted Therapy

James R. Tonra, Dhanvanthri S. Deevi, Erik Corcoran et al. · Clinical Cancer Research · 2006 · 150 citations

Medicine, Oncology, Pharmacology +17

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target

Nick Loizos, Yan Xu, Jim Huber et al. · Molecular Cancer Therapeutics · 2005 · 119 citations

Medicine, Oncology, Pharmacology +17

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i>

Anthony Cacciapuoti, David Loebenberg, Erik Corcoran et al. · Antimicrobial Agents and Chemotherapy · 2000 · 99 citations · Full text

Medicine, Microbiology, Pharmacology +15